A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical ModelsJeffrey L. Brown, David C. Blakey|Molecular Cancer Therapeutics|2010Cited by 153